Brief: Euroapi, Priothera Sign CDMO Agreement To Advance Oncology Project
18/06/2024 06:09
June 18 (Reuters) - Euroapi SA EAPI.PA :
* EUROAPI AND PRIOTHERA ENTER INTO CDMO COLLABORATION TO
ADVANCE
ONCOLOGY PROJECT
* EUROAPI WILL DEVELOP AND INDUSTRIALIZE MANUFACTURING
PROCESS OF
INNOVATIVE COMPLEX MOLECULE FOR BLOOD CANCERS
* EUROAPI AND PRIOTHERA, HAVE SIGNED A 5-YEAR CDMO AGREEMENT
* BRINGS A SUBSTANTIAL VALUE TO PRIOTHERA WHO IS
ACCELERATING ITS
LATE DEVELOPMENT OF MOCRAVIMOD IN A GLOBAL PHASE 3 CLINICAL
STUDY
* WITH A VIEW OF WORLDWIDE DRUG REGISTRATION AND
COMMERCIALIZATION
BY 2027
Source text for Workspace: ID:nGNEbSZkqN
Further company coverage: EAPI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))